why choose us

First received: July 28, 2022

Clinical Trial: Biomarkers of Cognitive Impairment in Blood Cells

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mild Cognitive Impairment Due to Alzheimer's Disease

Study Type: OBSERVATIONAL


Official Title: Use of Human Blood Cells for the Identification of Early Biomarkers of Cognitive Damage

Brief Summary: The aim of this study is to identify transcriptomic biomarkers in blood cells to diagnose early cognitive impairment.This would allow preventing the development of severe pathologies, such as Alzheimer Disease.In addition, this project will analyse the influence of adiposity, obesity, nutritional habits and physical activity on cognition.

Read more